Toll Free: 1-888-928-9744
Published: Sep, 2014 | Pages:
31 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
JCR Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'JCR Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the JCR Pharmaceuticals Co., Ltd.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of JCR Pharmaceuticals Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of JCR Pharmaceuticals Co., Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of JCR Pharmaceuticals Co., Ltd.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the JCR Pharmaceuticals Co., Ltd.'s pipeline products Reasons to buy - Evaluate JCR Pharmaceuticals Co., Ltd.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of JCR Pharmaceuticals Co., Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the JCR Pharmaceuticals Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of JCR Pharmaceuticals Co., Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of JCR Pharmaceuticals Co., Ltd. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of JCR Pharmaceuticals Co., Ltd. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 JCR Pharmaceuticals Co., Ltd. Snapshot 5 JCR Pharmaceuticals Co., Ltd. Overview 5 Key Information 5 Key Facts 5 JCR Pharmaceuticals Co., Ltd. - Research and Development Overview 6 Key Therapeutic Areas 6 JCR Pharmaceuticals Co., Ltd. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Pipeline Products - Out-Licensed Products 12 Out-Licensed Products/Combination Treatment Modalities 13 JCR Pharmaceuticals Co., Ltd. - Pipeline Products Glance 14 JCR Pharmaceuticals Co., Ltd. - Clinical Stage Pipeline Products 14 Phase II Products/Combination Treatment Modalities 14 JCR Pharmaceuticals Co., Ltd. - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 JCR Pharmaceuticals Co., Ltd. - Drug Profiles 16 JR-031 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 darbepoetin alfa 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 JR-032 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 JR-051 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 JR-101 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 JCR Pharmaceuticals Co., Ltd. - Pipeline Analysis 22 JCR Pharmaceuticals Co., Ltd. - Pipeline Products by Target 22 JCR Pharmaceuticals Co., Ltd. - Pipeline Products by Route of Administration 23 JCR Pharmaceuticals Co., Ltd. - Pipeline Products by Molecule Type 24 JCR Pharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action 25 JCR Pharmaceuticals Co., Ltd. - Dormant Projects 26 JCR Pharmaceuticals Co., Ltd. - Company Statement 27 JCR Pharmaceuticals Co., Ltd. - Locations And Subsidiaries 28 Head Office 28 Other Locations & Subsidiaries 28 Appendix 30 Methodology 30 Coverage 30 Secondary Research 30 Primary Research 30 Expert Panel Validation 30 Contact Us 31 Disclaimer 31
List of Tables JCR Pharmaceuticals Co., Ltd., Key Information 5 JCR Pharmaceuticals Co., Ltd., Key Facts 5 JCR Pharmaceuticals Co., Ltd. - Pipeline by Indication, 2014 7 JCR Pharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2014 8 JCR Pharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2014 9 JCR Pharmaceuticals Co., Ltd. - Partnered Products in Pipeline, 2014 10 JCR Pharmaceuticals Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 11 JCR Pharmaceuticals Co., Ltd. - Out-Licensed Products in Pipeline, 2014 12 JCR Pharmaceuticals Co., Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2014 13 JCR Pharmaceuticals Co., Ltd. - Phase II, 2014 14 JCR Pharmaceuticals Co., Ltd. - Preclinical, 2014 15 JCR Pharmaceuticals Co., Ltd. - Pipeline by Target, 2014 22 JCR Pharmaceuticals Co., Ltd. - Pipeline by Route of Administration, 2014 23 JCR Pharmaceuticals Co., Ltd. - Pipeline by Molecule Type, 2014 24 JCR Pharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action, 2014 25 JCR Pharmaceuticals Co., Ltd. - Dormant Developmental Projects,2014 26 JCR Pharmaceuticals Co., Ltd., Other Locations 28 JCR Pharmaceuticals Co., Ltd., Subsidiaries 29
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.